These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 16354598

  • 1. Effects of soluble TNF receptor II (sTNF-RII), IL-1 receptor antagonist (IL-1ra), tumor load and hypermetabolism on malnutrition in children with acute leukemia.
    Schmid I, Schmitt M, Streiter M, Meilbeck R, Haas RJ, Stachel DK.
    Eur J Med Res; 2005 Nov 16; 10(11):457-61. PubMed ID: 16354598
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a.
    Perini P, Tiberio M, Sivieri S, Facchinetti A, Biasi G, Gallo P.
    Eur Cytokine Netw; 2000 Mar 16; 11(1):81-6. PubMed ID: 10705303
    [Abstract] [Full Text] [Related]

  • 3. Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis.
    Muzaffer MA, Dayer JM, Feldman BM, Pruzanski W, Roux-Lombard P, Schneider R, Laxer RM, Silverman ED.
    J Rheumatol; 2002 May 16; 29(5):1071-8. PubMed ID: 12022325
    [Abstract] [Full Text] [Related]

  • 4. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
    Rutkowski P, Kamińska J, Kowalska M, Ruka W, Steffen J.
    J Surg Oncol; 2003 Nov 16; 84(3):151-9. PubMed ID: 14598359
    [Abstract] [Full Text] [Related]

  • 5. Soluble cytokine receptors sTNFR I and sTNFR II, receptor antagonist IL-1ra, and anti-inflammatory cytokines IL-10 and IL-13 in the pathogenesis of systemic inflammatory response syndrome in the course of burns in children.
    Sikora JP, Kuzański W, Andrzejewska E.
    Med Sci Monit; 2009 Jan 16; 15(1):CR26-31. PubMed ID: 19114968
    [Abstract] [Full Text] [Related]

  • 6. Elevated serum tumor necrosis factor-alpha and soluble tumor necrosis factor receptors correlate with aberrant energy metabolism in liver cirrhosis.
    Shiraki M, Terakura Y, Iwasa J, Shimizu M, Miwa Y, Murakami N, Nagaki M, Moriwaki H.
    Nutrition; 2010 Mar 16; 26(3):269-75. PubMed ID: 19695831
    [Abstract] [Full Text] [Related]

  • 7. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
    Gabay C, Cakir N, Moral F, Roux-Lombard P, Meyer O, Dayer JM, Vischer T, Yazici H, Guerne PA.
    J Rheumatol; 1997 Feb 16; 24(2):303-8. PubMed ID: 9034987
    [Abstract] [Full Text] [Related]

  • 8. Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.
    Glossop JR, Dawes PT, Nixon NB, Mattey DL.
    Arthritis Res Ther; 2005 Feb 16; 7(6):R1227-34. PubMed ID: 16277675
    [Abstract] [Full Text] [Related]

  • 9. Human soluble tumor necrosis factor receptor I (sTNF-RI) and interleukin-I receptor antagonist (IL-I Ra) in different stages of acute rheumatic fever.
    Kütükçüler N, Karaca NE, Sözeri BY, Koturoğlu G, Kurugöl Z, Ozyürek RA, Aksu G.
    Anadolu Kardiyol Derg; 2008 Apr 16; 8(2):139-42. PubMed ID: 18400635
    [Abstract] [Full Text] [Related]

  • 10. [Soluble cytokinin receptors in renal vasculitis and lupus nephritis].
    Tesar V, Jirsa M, Masek Z, Bartůnková J, Stejskalová A, Dostál C, Zabka J, Chábová V, Rysavá R.
    Cas Lek Cesk; 1998 May 04; 137(9):271-5. PubMed ID: 9650355
    [Abstract] [Full Text] [Related]

  • 11. Soluble cytokine receptors in renal vasculitis and lupus nephritis.
    Tesar V, Jirsa M, Zima T, Kalousová M, Bartunková J, Stejskalová A, Dostál C, Zabka J.
    Med Sci Monit; 2002 Jan 04; 8(1):BR24-9. PubMed ID: 11782670
    [Abstract] [Full Text] [Related]

  • 12. Release of soluble tumor necrosis factor receptors from polymorphonuclear cells of breast cancer patients.
    Jabłońska E, Pietruska Z.
    Arch Immunol Ther Exp (Warsz); 1997 Jan 04; 45(5-6):449-53. PubMed ID: 9437501
    [Abstract] [Full Text] [Related]

  • 13. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer.
    Wang HJ, Yu CL, Kishi H, Motoki K, Mao ZB, Muraguchi A.
    Chin Med J (Engl); 2006 Aug 20; 119(16):1365-73. PubMed ID: 16934183
    [Abstract] [Full Text] [Related]

  • 14. Interleukin 1 beta, tumour necrosis factor-alpha and interleukin 1 receptor antagonist in newly diagnosed insulin-dependent diabetes mellitus: comparison to long-standing diabetes and healthy individuals.
    Netea MG, Hancu N, Blok WL, Grigorescu-Sido P, Popa L, Popa V, van der Meer JW.
    Cytokine; 1997 Apr 20; 9(4):284-7. PubMed ID: 9112337
    [Abstract] [Full Text] [Related]

  • 15. Reduced mortality and CD4 cell loss among carriers of the interleukin-10 -1082G allele in a Zimbabwean cohort of HIV-1-infected adults.
    Erikstrup C, Kallestrup P, Zinyama-Gutsire RB, Gomo E, Butterworth AE, Pedersen BK, Ostrowski SR, Gerstoft J, Ullum H.
    AIDS; 2007 Nov 12; 21(17):2283-91. PubMed ID: 18090276
    [Abstract] [Full Text] [Related]

  • 16. Nutrition, anthropometry, gastrointestinal dysfunction, and circulating levels of tumour necrosis factor alpha receptor I and interleukin-1 receptor antagonist in children during stem cell transplantation.
    Andreassen BU, Paerregaard A, Michaelsen KF, Andersen J, Heilmann CJ, Müller K.
    Pediatr Transplant; 2009 Mar 12; 13(2):182-7. PubMed ID: 18482213
    [Abstract] [Full Text] [Related]

  • 17. Induction of serum soluble tumor necrosis factor receptor II (sTNF-RII) and interleukin-1 receptor antagonist (IL-1ra) by interferon beta-1b in patients with progressive multiple sclerosis.
    Comabella M, Julià E, Tintoré M, Brieva L, Téllez N, Río J, López C, Rovira A, Montalban X.
    J Neurol; 2008 Aug 12; 255(8):1136-41. PubMed ID: 18484235
    [Abstract] [Full Text] [Related]

  • 18. Elevation of soluble tumor necrosis factor receptor II in non-febrile patients with acute myeloid leukemia.
    Goetz M, Schiel X, Heussel H, Steinmetz T, Hiddemann W, Weiss M.
    Eur J Med Res; 2002 Nov 25; 7(11):487-90. PubMed ID: 12568977
    [Abstract] [Full Text] [Related]

  • 19. Elevation of serum soluble tumour necrosis factor (TNF) receptor and IL-1 receptor antagonist levels in bronchial asthma.
    Yoshida S, Hashimoto S, Nakayama T, Kobayashi T, Koizumi A, Horie T.
    Clin Exp Immunol; 1996 Oct 25; 106(1):73-8. PubMed ID: 8870701
    [Abstract] [Full Text] [Related]

  • 20. Soluble TNF-alpha receptor and IL-1 receptor antagonist elevation in BAL in active pulmonary TB.
    Tsao TC, Li L, Hsieh M, Liao S, Chang KS.
    Eur Respir J; 1999 Sep 25; 14(3):490-5. PubMed ID: 10543265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.